<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">Nature and Science of Sleep</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27051325</article-id>
      <article-id pub-id-type="pmc">4807943</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S106224</article-id>
      <article-id pub-id-type="publisher-id">nss-8-087</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Editorial</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Are we underestimating the lifelong benefits of therapy for obstructive sleep apnea?</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Berman</surname>
            <given-names>Alec M</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-8-087"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thosar</surname>
            <given-names>Saurabh S</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-8-087"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shea</surname>
            <given-names>Steven A</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-8-087"/>
          <xref ref-type="corresp" rid="c1-nss-8-087"/>
        </contrib>
      </contrib-group>
      <aff id="af1-nss-8-087">Oregon Institute of Occupational Health Sciences, Oregon Health and Science University, Portland, OR, USA</aff>
      <author-notes>
        <corresp id="c1-nss-8-087">Correspondence: Steven A Shea, Oregon Institute of Occupational Health Sciences, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239, USA, Email <email>sheast@ohsu.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>3</month>
        <year>2016</year>
      </pub-date>
      <volume>8</volume>
      <fpage>87</fpage>
      <lpage>89</lpage>
      <permissions>
        <copyright-statement>© 2016 Berman et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license>
          <license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p><citation_analysis attribute="negative">Obstructive sleep apnea (OSA) is a complex disorder involving the cardiovascular (CV), pulmonary, and metabolic systems. Characterized by marked daytime fatigue and reduced quality of life, OSA is independently associated with increased risk of hypertension,</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-8-087" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither"> cardiovascular disease (CVD),</citation_analysis><citation_analysis attribute="positive"><xref rid="b2-nss-8-087" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> including myocardial infarction (MI)</citation_analysis><citation_analysis attribute="positive"><xref rid="b3-nss-8-087" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> and ischemic stroke,</citation_analysis><citation_analysis attribute="positive"><xref rid="b4-nss-8-087" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither"> metabolic syndrome,</citation_analysis><citation_analysis attribute="positive"><xref rid="b5-nss-8-087" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither"> and all-cause mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="b6-nss-8-087" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="positive"> Currently, the most common treatment for OSA is continuous positive airway pressure (CPAP) during sleep, though its efficacy in reducing daytime fatigue and CVD risk factors depends largely on compliance to therapy, which is poor in the general population.</citation_analysis><citation_analysis attribute="positive"><xref rid="b7-nss-8-087" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> Lamberts et al</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-8-087" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"> performed a large epidemiological study of OSA, using the Danish National Patient Registry (NPR; ~4.5 million; including 25,389 people diagnosed with OSA), which confirmed associations between OSA and risk of ischemic stroke and MI. Yet, that study failed to show that CPAP reduces the incidence of these adverse CV events.</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-8-087" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> On the other hand, a more recent study, which examined the same Danish NPR across a very similar time period, revealed that in people with OSA, CPAP reduces all-cause mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-8-087" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> This editorial evaluates these seemingly conflicting results, whereby CPAP appears to reduce mortality but not two of the largest contributors to mortality: stroke and MI.</citation_analysis></p>
    <p><citation_analysis attribute="positive">Of interest, the study by Lamberts et al found that the associations between OSA and risk of MI and ischemic stroke occurred only in young people (aged 18–49 years).</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-8-087" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> However, the prevalence of OSA in this sample was only 0.7%, which is lower than in most other random populations (3%–7%).</citation_analysis><citation_analysis attribute="positive"><xref rid="b10-nss-8-087" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="positive"> Thus, many people with undiagnosed OSA likely contributed to the NPR control group, thereby biasing toward the null hypothesis and perhaps explaining the lack of an OSA effect in the older groups. Additionally, these authors were unable to find an effect of CPAP on stroke or MI incidence in any age-group. However, they do suggest that use of CPAP in the younger population with high CV risk warrants further investigation. This seems reasonable, especially considering possible benefits of CPAP on symptoms of daytime sleepiness,</citation_analysis><citation_analysis attribute="positive"><xref rid="b11-nss-8-087" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> plus the known CV benefits of CPAP, including reductions in both nocturnal and daytime blood pressure.</citation_analysis><citation_analysis attribute="positive"><xref rid="b12-nss-8-087" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b14-nss-8-087" ref-type="bibr">14</xref></citation_analysis><citation_analysis attribute="positive"> Thus, starting therapy earlier in life has a greater potential to reduce the long-term effects of OSA on the CV system, including reducing the burden of hypertension.</citation_analysis><citation_analysis attribute="positive"><xref rid="b15-nss-8-087" ref-type="bibr">15</xref></citation_analysis><citation_analysis attribute="neither"> Should CPAP also be recommended for older people with OSA for CV outcomes alone? Lamberts et al</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-8-087" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"> claim that OSA may have less of a role in the development of CVD in the elderly because the emergence of other CV risk factors, including hypertension, may attenuate the relative contribution of OSA to MI and stroke. However, given the findings by Jennum et al,</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-8-087" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> we believe a reinterpretation is warranted. This newer analysis revealed that CPAP therapy improves survival rate by approximately 30% in middle-aged and elderly men.</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-8-087" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="positive"> Furthermore, two main limitations of this study may have resulted in an underestimate of the benefits of CPAP, as partly acknowledged by these authors. First, there was no information on the severity of sleep apnea (eg, the apnea-hypopnea index [AHI]). Since people with more severe symptoms are more likely to be treated, we contend that the group that received CPAP likely had higher OSA burden at the onset of the study. If the disease burden was higher and yet survival improved, then the benefits of CPAP would be underestimated. Second, there was no information on CPAP adherence: if adherence was poor yet survival improved, this would also underestimate the potential benefit of consistently used CPAP.</citation_analysis></p>
    <p><citation_analysis attribute="neither">Additionally, Jennum et al failed to find an effect of CPAP in the younger cohort (aged 20–39 years) and in women of any age. But, given the protective CV effect female sex has prior to menopause,</citation_analysis><citation_analysis attribute="positive"><xref rid="b16-nss-8-087" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="negative"> and the relatively low inherent risk of dying in the young, we would not expect CPAP therapy to affect mortality rates in populations with such low vulnerability (given the short duration of the study relative to life expectancy).</citation_analysis></p>
    <p><citation_analysis attribute="positive">Taken together, we feel these studies provide strong evidence for the benefits of CPAP therapy across the life spans of people with OSA. In the young, CPAP reduces hypertension and may reduce the risk of an early-life adverse CV event.</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-8-087" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="positive"> In middle-aged and elderly people with OSA, CPAP improves overall survival possibly via similar effects on the CV system.</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-8-087" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="positive"> Such beneficial effects of CPAP could presumably be extrapolated to any other therapy that reduces the AHI. There are numerous other emerging therapies for OSA</citation_analysis><citation_analysis attribute="positive"><xref rid="b17-nss-8-087" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> and great effort to improve adherence to CPAP therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-8-087" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> Thus, future clinical trials of therapies for OSA ideally should employ large population approaches, and include randomized comparative-effectiveness trials, or placebo-controlled trials (eg, The Apnea Positive Pressure Long-term Efficacy Study).</citation_analysis><citation_analysis attribute="positive"><xref rid="b19-nss-8-087" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="positive"> Additionally, incorporation of information on adherence to therapy, plus important health status indicators such as blood pressure, AHI, and body mass index will aid investigation of the associations between OSA disease burden, CV risk, and the effect of therapy on survival.</citation_analysis></p>
  </body>
  <back>
    <fn-group>
      <fn>
        <p><citation_analysis attribute="positive">
          </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
        </citation_analysis></p>
        <p><citation_analysis attribute="neither">The authors report no conflicts of interest in this work.</citation_analysis></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-nss-8-087">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavie</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Herer</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Hoffstein</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study</article-title>
          <source>BMJ</source>
          <year>2000</year>
          <volume>320</volume>
          <issue>7233</issue>
          <fpage>479</fpage>
          <lpage>482</lpage>
          <pub-id pub-id-type="pmid">10678860</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-nss-8-087">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shahar</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Whitney</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Redline</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2001</year>
          <volume>163</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">11208620</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-nss-8-087">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hung</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Whitford</surname>
              <given-names>EG</given-names>
            </name>
            <name>
              <surname>Parsons</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Hillman</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Association of sleep apnoea with myocardial infarction in men</article-title>
          <source>Lancet</source>
          <year>1990</year>
          <volume>336</volume>
          <issue>8710</issue>
          <fpage>261</fpage>
          <lpage>264</lpage>
          <pub-id pub-id-type="pmid">1973968</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-nss-8-087">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yaggi</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Concato</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kernan</surname>
              <given-names>WN</given-names>
            </name>
            <name>
              <surname>Lichtman</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Brass</surname>
              <given-names>LM</given-names>
            </name>
            <name>
              <surname>Mohsenin</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Obstructive sleep apnea as a risk factor for stroke and death</article-title>
          <source>N Engl J Med</source>
          <year>2005</year>
          <volume>353</volume>
          <issue>19</issue>
          <fpage>2034</fpage>
          <lpage>2041</lpage>
          <pub-id pub-id-type="pmid">16282178</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-nss-8-087">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coughlin</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Mawdsley</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mugarza</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Calverley</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Wilding</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome</article-title>
          <source>Eur Heart J</source>
          <year>2004</year>
          <volume>25</volume>
          <issue>9</issue>
          <fpage>735</fpage>
          <lpage>741</lpage>
          <pub-id pub-id-type="pmid">15120883</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-nss-8-087">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>KK</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Cullen</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Knuiman</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Grunstein</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study</article-title>
          <source>Sleep</source>
          <year>2008</year>
          <volume>31</volume>
          <issue>8</issue>
          <fpage>1079</fpage>
          <lpage>1085</lpage>
          <pub-id pub-id-type="pmid">18714779</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-nss-8-087">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaver</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Grunstein</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Adherence to continuous positive airway pressure therapy: the challenge to effective treatment</article-title>
          <source>Proc Am Thorac Soc</source>
          <year>2008</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>173</fpage>
          <lpage>178</lpage>
          <pub-id pub-id-type="pmid">18250209</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-nss-8-087">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lamberts</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nielsen</surname>
              <given-names>OW</given-names>
            </name>
            <name>
              <surname>Lip</surname>
              <given-names>GY</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cardiovascular risk in patients with sleep apnoea with or without continuous positive airway pressure therapy: follow-up of 4.5 million Danish adults</article-title>
          <source>J Intern Med</source>
          <year>2014</year>
          <volume>276</volume>
          <issue>6</issue>
          <fpage>659</fpage>
          <lpage>666</lpage>
          <pub-id pub-id-type="pmid">25169419</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-nss-8-087">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jennum</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Tønnesen</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ibsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Kjellberg</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>All-cause mortality from obstructive sleep apnea in male and female patients with and without continuous positive airway pressure treatment: a registry study with 10 years of follow-up</article-title>
          <source>Nat Sci Sleep</source>
          <year>2015</year>
          <volume>7</volume>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">25914563</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-nss-8-087">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Punjabi</surname>
              <given-names>NM</given-names>
            </name>
          </person-group>
          <article-title>The epidemiology of adult obstructive sleep apnea</article-title>
          <source>Proc Am Thorac Soc</source>
          <year>2008</year>
          <volume>5</volume>
          <issue>2</issue>
          <fpage>136</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">18250205</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-nss-8-087">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marshall</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Barnes</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Travier</surname>
              <given-names>N</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Continuous positive airway pressure reduces daytime sleepiness in mild to moderate obstructive sleep apnoea: a meta-analysis</article-title>
          <source>Thorax</source>
          <year>2006</year>
          <volume>61</volume>
          <issue>5</issue>
          <fpage>430</fpage>
          <lpage>434</lpage>
          <pub-id pub-id-type="pmid">16467072</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-nss-8-087">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lozano</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tovar</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Sampol</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial</article-title>
          <source>J Hypertens</source>
          <year>2010</year>
          <volume>28</volume>
          <issue>10</issue>
          <fpage>2161</fpage>
          <lpage>2168</lpage>
          <pub-id pub-id-type="pmid">20577130</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-nss-8-087">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Agrawal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Damodaran</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>CPAP for the metabolic syndrome in patients with obstructive sleep apnea</article-title>
          <source>N Engl J Med</source>
          <year>2011</year>
          <volume>365</volume>
          <issue>24</issue>
          <fpage>2277</fpage>
          <lpage>2286</lpage>
          <pub-id pub-id-type="pmid">22168642</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-nss-8-087">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martínez-García</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Capote</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Campos-Rodriguez</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial</article-title>
          <source>JAMA</source>
          <year>2013</year>
          <volume>310</volume>
          <issue>22</issue>
          <fpage>2407</fpage>
          <lpage>2415</lpage>
          <pub-id pub-id-type="pmid">24327037</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-nss-8-087">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Staessen</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Thijs</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Cardiovascular protection and blood pressure reduction: a meta-analysis</article-title>
          <source>Lancet</source>
          <year>2001</year>
          <volume>358</volume>
          <issue>9290</issue>
          <fpage>1305</fpage>
          <lpage>1315</lpage>
          <pub-id pub-id-type="pmid">11684211</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-nss-8-087">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Khodneva</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk of incident coronary heart disease events in men compared to women by menopause type and race</article-title>
          <source>J Am Heart Assoc</source>
          <year>2015</year>
          <volume>4</volume>
          <issue>7</issue>
          <comment>pii: e001881</comment>
        </element-citation>
      </ref>
      <ref id="b17-nss-8-087">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weaver</surname>
              <given-names>TE</given-names>
            </name>
            <name>
              <surname>Calik</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Farabi</surname>
              <given-names>SS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Innovative treatments for adults with obstructive sleep apnea</article-title>
          <source>Nat Sci Sleep</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>137</fpage>
          <lpage>147</lpage>
          <pub-id pub-id-type="pmid">25429246</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-nss-8-087">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Engleman</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Wild</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS)</article-title>
          <source>Sleep Med Rev</source>
          <year>2003</year>
          <volume>7</volume>
          <issue>1</issue>
          <fpage>81</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="pmid">12586532</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-nss-8-087">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kushida</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Holmes</surname>
              <given-names>TH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES)</article-title>
          <source>Sleep</source>
          <year>2012</year>
          <volume>35</volume>
          <issue>12</issue>
          <fpage>1593</fpage>
          <lpage>1602</lpage>
          <pub-id pub-id-type="pmid">23204602</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
